Alphabet’s Isomorphic Labs reportedly raising $2B+ for its medical research AI

Isomorphic Labs Inc., an Alphabet Inc. unit using artificial intelligence to speed up drug development, is reportedly in talks to raise a new funding round. Sources told Bloomberg today that the investment could be worth more than $2 billion.